Amgen Inc.

BOVESPA:AMGN34 Stock Report

Market Cap: R$919.1b

Amgen Future Growth

Future criteria checks 3/6

Amgen is forecast to grow earnings and revenue by 19.1% and 2.5% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 205.5% in 3 years.

Key information

19.1%

Earnings growth rate

19.6%

EPS growth rate

Biotechs earnings growth31.6%
Revenue growth rate2.5%
Future return on equity205.5%
Analyst coverage

Good

Last updated20 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:AMGN34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202634,9527,60713,89413,87824
12/31/202534,2766,52912,43913,04628
12/31/202433,1724,79412,25012,96427
9/30/202432,5344,2306,2837,257N/A
6/30/202430,9343,1305,4816,446N/A
3/31/202429,5323,7637,0988,096N/A
12/31/202328,1906,7177,3598,471N/A
9/30/202326,8337,5669,37910,582N/A
6/30/202326,5827,9799,68510,800N/A
3/31/202326,1907,9177,5318,621N/A
12/31/202226,3236,5528,7859,721N/A
9/30/202226,3306,8358,9979,880N/A
6/30/202226,3846,5768,3559,320N/A
3/31/202226,3165,7238,4179,321N/A
12/31/202125,9795,8938,3819,261N/A
9/30/202125,7675,6097,8408,606N/A
6/30/202125,4845,7468,8979,556N/A
3/31/202125,1647,0859,83510,467N/A
12/31/202025,4247,2649,88910,497N/A
9/30/202024,9877,35210,23510,858N/A
6/30/202024,3017,29910,20910,867N/A
3/31/202023,9667,6758,7959,439N/A
12/31/201923,3627,8428,5329,150N/A
9/30/201923,3958,0679,1759,830N/A
6/30/201923,5627,9589,0709,726N/A
3/31/201923,7508,0759,71510,414N/A
12/31/201823,7478,39410,55811,296N/A
9/30/201823,3192,20210,44811,114N/A
6/30/201823,1882,364N/A11,295N/A
3/31/201822,9392,219N/A11,519N/A
12/31/201722,8491,979N/A11,177N/A
9/30/201723,0128,178N/A11,265N/A
6/30/201723,0508,174N/A10,473N/A
3/31/201722,9287,893N/A10,824N/A
12/31/201622,9917,722N/A10,354N/A
9/30/201622,5627,587N/A9,327N/A
6/30/201622,4747,433N/A9,557N/A
3/31/201622,1567,216N/A10,164N/A
12/31/201521,6626,939N/A9,731N/A
9/30/201521,4576,433N/A10,103N/A
6/30/201520,7655,814N/A9,952N/A
3/31/201520,5755,708N/A8,895N/A
12/31/201420,0635,158N/A8,952N/A
9/30/201419,7434,885N/A7,945N/A
6/30/201419,4605,009N/A7,011N/A
3/31/201418,9594,720N/A6,384N/A
12/31/201318,6765,081N/A6,291N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMGN34's forecast earnings growth (19.1% per year) is above the savings rate (10.4%).

Earnings vs Market: AMGN34's earnings (19.1% per year) are forecast to grow faster than the BR market (12.5% per year).

High Growth Earnings: AMGN34's earnings are forecast to grow, but not significantly.

Revenue vs Market: AMGN34's revenue (2.5% per year) is forecast to grow slower than the BR market (7.5% per year).

High Growth Revenue: AMGN34's revenue (2.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AMGN34's Return on Equity is forecast to be very high in 3 years time (205.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y